Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?

Core Viewpoint - The First Trust Health Care AlphaDEX ETF (FXH) is a passively managed ETF that provides broad exposure to the Healthcare - Broad segment of the equity market, appealing to both institutional and retail investors due to its low cost and tax efficiency [1][2]. Group 1: ETF Overview - FXH was launched on May 8, 2007, and has accumulated over $857.74 million in assets, making it one of the larger ETFs in its category [3]. - The ETF aims to match the performance of the StrataQuant Health Care Index, utilizing the AlphaDEX stock selection methodology to choose stocks from the Russell 1000 Index [3]. Group 2: Costs and Performance - FXH has annual operating expenses of 0.6% and a 12-month trailing dividend yield of 0.34%, which is competitive within its peer group [4]. - The ETF has experienced a loss of approximately 3.39% year-to-date and about 8.07% over the past year, with a trading range between $93.63 and $113.828 in the last 52 weeks [7]. Group 3: Sector Exposure and Holdings - The ETF is fully allocated to the Healthcare sector, with Biogen Inc. (BIIB) representing about 2.36% of total assets, and the top 10 holdings accounting for approximately 23.06% of total assets under management [5][6]. Group 4: Alternatives and Comparisons - FXH carries a Zacks ETF Rank of 3 (Hold), indicating it is a reasonable option for investors seeking exposure to healthcare ETFs [8]. - Other alternatives include the Vanguard Health Care ETF (VHT) with $15.18 billion in assets and an expense ratio of 0.09%, and the Health Care Select Sector SPDR ETF (XLV) with $33.05 billion in assets and an expense ratio of 0.08% [9].